Medical Treatment of Mesothelioma: Anything New?

Consolidative Dendritic Cell-based Immunotherapy Elicits Cytotoxicity against Malignant Mesothelioma

(2010) Joost P. Hegmans et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Asbestos, Lung Cancers, and Mesotheliomas

(2010) Nicholas H. Heintz et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

New tricks for old biomarkers: thymidylate synthase expression as a predictor of pemetrexed activity in malignant mesothelioma

(2010) P. A. Zucali et al.   ANNALS OF ONCOLOGY

Pemetrexed Safety and Pharmacokinetics in Patients with Third-Space Fluid

(2010) N. J. Dickgreber et al.   CLINICAL CANCER RESEARCH

Valproate-doxorubicin: promising therapy for progressing mesothelioma. A phase II study

(2010) A. Scherpereel et al.   EUROPEAN RESPIRATORY JOURNAL

Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial

(2010) P. E. Van Schil et al.   EUROPEAN RESPIRATORY JOURNAL

Proton Therapy for Malignant Pleural Mesothelioma After Extrapleural Pleuropneumonectomy

(2010) Jerôme Krayenbuehl et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Volumetric Modulation Arc Radiotherapy Compared With Static Gantry Intensity-Modulated Radiotherapy for Malignant Pleural Mesothelioma Tumor: A Feasibility Study

(2010) Marta Scorsetti et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Phase II Study of Asparagine-Glycine-Arginine–Human Tumor Necrosis Factor α, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma

(2010) Vanesa Gregorc et al.   JOURNAL OF CLINICAL ONCOLOGY

Thymidylate Synthase But Not Excision Repair Cross-Complementation Group 1 Tumor Expression Predicts Outcome in Patients With Malignant Pleural Mesothelioma Treated With Pemetrexed-Based Chemotherapy

(2010) Luisella Righi et al.   JOURNAL OF CLINICAL ONCOLOGY

Trimodality Treatment of Malignant Pleural Mesothelioma

(2010) Hasan Fevzi Batirel et al.   Journal of Thoracic Oncology

Phase II Study of Belinostat (PXD101), a Histone Deacetylase Inhibitor, for Second Line Therapy of Advanced Malignant Pleural Mesothelioma

(2010) Suresh S. Ramalingam et al.   Journal of Thoracic Oncology

Histone Deacetylase Inhibitors in Malignant Pleural Mesothelioma: Preclinical Rationale and Clinical Trials

(2010) Paul K. Paik et al.   Journal of Thoracic Oncology

A Systematic Review of Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma

(2010) Christopher Q. Cao et al.   Journal of Thoracic Oncology

What's the place of immunotherapy in malignant mesothelioma treatments?

(2010) Marc Grégoire   Cell Adhesion & Migration

Second-line treatment for malignant pleural mesothelioma

(2009) Giovanni Luca Ceresoli et al.   CANCER TREATMENT REVIEWS

Malignant Pleural Mesothelioma

(2009) Mandira Ray et al.   CHEST

Molecular Targets in Malignant Pleural Mesothelioma Treatment

(2009) Giulia Pasello et al.   CURRENT DRUG TARGETS

Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural Mesothelioma

(2009) Lee M. Krug et al.   JOURNAL OF CLINICAL ONCOLOGY

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience

(2009) Tristan D. Yan et al.   JOURNAL OF CLINICAL ONCOLOGY

Malignant Pleural Mesothelioma

(2009) Anne S. Tsao et al.   JOURNAL OF CLINICAL ONCOLOGY

Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: A phase II prospective study

(2009) Tamara R. Tilleman et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

The Mesothelioma and Radical Surgery Randomized Controlled Trial: The MARS Feasibility Study

(2009) Tom Treasure et al.   Journal of Thoracic Oncology

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study

(2009) Tudor Ciuleanu et al.   LANCET

Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials

(2008) G L Ceresoli et al.   BRITISH JOURNAL OF CANCER

Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma

(2008) Paolo A. Zucali et al.   CANCER

US mesothelioma patterns 1973–2002: indicators of change and insights into background rates

(2008) Mary Jane Teta et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Pemetrexed Plus Gemcitabine As First-Line Chemotherapy for Patients With Peritoneal Mesothelioma: Final Report of a Phase II Trial

(2008) George R. Simon et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Trial of Pemetrexed and Gemcitabine in Chemotherapy-Naïve Malignant Pleural Mesothelioma

(2008) Pasi A. Jänne et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Trial of Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care in Previously Treated Patients With Advanced Malignant Pleural Mesothelioma

(2008) Jacek Jassem et al.   JOURNAL OF CLINICAL ONCOLOGY

Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patients

(2008) Raja M. Flores et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial

(2008) Martin F Muers et al.   LANCET

The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma

(2008) Justin Stebbing et al.   LUNG CANCER